FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION
Benchmark Implementation | Morimatsu Successfully Delivers Vial Filling Line, Empowering Large-Scale Production of High-End Sterile Preparations
Time:2026-05-12 15:13:09

Recently, following in-depth research, dedicated development and stringent testing, Morimatsu has successfully delivered the vial filling line to the customer. This marks not only an important milestone for Morimatsu in the field of intelligent pharmaceutical equipment, but also a vivid practice of honoring commitments with professional expertise and safeguarding health with Morimatsu quality. It signifies a new breakthrough in Morimatsu’s capabilities in the R&D, manufacturing and delivery of vial filling lines, injecting strong equipment support for the large-scale and standardized production of high-end preparations by pharmaceutical enterprises at home and abroad.

As a core equipment specifically designed for sterile preparations, this vial filling line carries the trust and expectations of clients, embodying the dedication and perseverance of the Morimatsu team. From in-depth technical exchanges and solution optimization in the early stages to meticulous quality control during the process, and further to on-site installation, debugging, and technical training in the later stages, Morimatsu has always maintained close collaboration and synchronization with clients.

01 Innovative Design:Multi-dimensional Technological Innovations Build Equipment Strength

This equipment is a benchmark product for Morimatsu in the vial filling line sector, featuring comprehensive technical updates and innovative upgrades in design. Centered on integration, intelligence, and precision, it establishes a fully automated production system from empty vial loading to finished product discharge. The equipment mainly consists of a vertical rotary bottle washer, customized tunnel oven, high-precision filling and stoppering machine, and intelligent capping mechanism. Core production processes are protected by Grade A laminar flow, achieving closed-loop control throughout the sterile production process. Its design innovations and technological breakthroughs are reflected in three key dimensions:

Optimized Structural Design, Strengthening the Foundation of Sterile Production
Addressing challenges such as significant temperature fluctuations in the sterilization zone of traditional ovens and SIP dead angles in the cooling zone, the tunnel oven structure has been newly optimized with comprehensive temperature validation. Through fluid dynamics simulation design, uniform heat distribution is achieved across every space in the oven's sterilization zone. Additionally, SIP dead angles in the cooling zone are technically eliminated, significantly reducing microbial contamination risks. Meanwhile, the filling and stoppering machine and capping mechanism provide first-pass laminar flow protection until the product is fully sealed, embedding sterile principles throughout the entire production process.

Material and Process Innovations, Enabling Easy Cleaning and Validation
All metal components in contact with pharmaceutical liquids are made of 316L stainless steel, combined with decades of Morimatsu welding expertise to achieve seamless integration and dead-angle-free design. The equipment fully supports CIP (Clean-in-Place) and SIP (Sterilize-in-Place), with cleaning and sterilization effects precisely verifiable, perfectly meeting the stringent cleanliness requirements for high-end preparation production.

Intelligent Drive Upgrade: Balancing Efficiency and Precision
The filling machine adopts a servo-driven dosing system, integrating Industry 4.0 concepts and equipped with a 100% IPC full weighing detection system. It monitors and adjusts filling volumes in real-time during production, perfectly meeting the demands of high-value pharmaceuticals. Additionally, it features a multi-specification quick-change module, enabling efficient switching between different bottle types without complex mold changes, balancing production efficiency and flexibility.

1.png

02 Quality Upgrade:Comprehensive Assurance of Production Stability

Morimatsu integrates stringent quality control into every detail of the equipment, from raw material procurement and component processing to assembly and factory validation. A full lifecycle quality assurance system ensures an all-round upgrade in equipment quality, safeguarding the stability of customer production:

Full-Process Oxidation Protection: Preserving Product Activity
For oxidation-sensitive high-value biologics, the equipment innovatively incorporates a triple nitrogen protection system during pre-filling, post-filling, and stoppering processes, ensuring nitrogen shielding throughout production. Residual oxygen levels are precisely controlled at ≤2%, maximizing product activity and stability.

End-to-End Compliance: Reducing Certification Risks
The equipment’s R&D and manufacturing strictly adhere to global regulatory standards including FDA, cGMP, EU GMP, NMPA GMP, WHO, PIC/S, GAMP5, and 21CFR Part 11. Complete validation documentation and compliance materials are provided to help customers effortlessly pass pharmaceutical regulatory audits, minimizing compliance costs and certification risks at the equipment level.

Rigorous Factory Validation: Ensuring Equipment Reliability
Leveraging multidisciplinary expertise in materials research, thermal analysis, and CFD applications, Morimatsu conducts comprehensive testing on equipment stability and durability to ensure rapid production deployment and fault-free operation upon delivery.

2.png

03 Value Empowerment:Comprehensive Assurance of Production Stability

The successful delivery of Morimatsu’s sterile vial filling line has not only provided customers with a high-end sterile preparation production line, but also created full-link core value for pharmaceutical companies across four dimensions: quality, efficiency, compliance and cost, serving as core equipment support for high-end preparation production.

1.Quality Value: An end-to-end sterile control system eliminates contamination sources at the equipment level, significantly reducing product contamination and rejection rates while ensuring consistent and controllable quality;

2.Efficiency Value: Fully automated synchronized production coupled with rapid multi-format changeovers dramatically enhances productivity and capacity while maintaining batch-to-batch consistency for scalable manufacturing;

3.Compliance Value: Full alignment with global regulatory standards, supported by complete validation documentation, accelerates certification processes and facilitates market access in domestic and international markets;

4.Cost Value: Integrated design simplifies production workflows, CIP/SIP online cleaning/sterilization reduces operational costs, and comprehensive compliance documentation minimizes validation investments, achieving long-term cost efficiency for enterprises.

3.png

Morimatsu's Integrated Pharmaceutical Solution
— Available Products and Services —

● Customized Integrated Solutions for Small to Medium Pilot Equipment
● Overall Solution for Sterile Vial Preparations
● Integrated Solutions for Sterile Formulation of Pre-filled Syringes
● Integrated Solutions for Eye Drops
● Integrated Solutions for Nasal Sprays
● Overall Solution for Freeze-Drying Systems
● Integrated Solutions for Isolation Systems
● Validation Services for Formulation Equipment
● Cost-Effective and Efficient Operation & Maintenance Solutions for Formulation Production Lines

Delivery is not the end, but a new beginning of collaboration. The successful delivery of this vial filling line is attributed to the trust of our clients and demonstrates Morimatsu's technical expertise and project execution capabilities in the pharmaceutical intelligent equipment sector. This achievement has accumulated valuable engineering experience for future projects, further solidifying our commitment to the pharmaceutical equipment industry. Moving forward, Morimatsu will focus on the industry's demand for intelligent and refined pharmaceutical production, continuously driving technological innovation and quality enhancement. We will optimize product solutions and service systems to provide more competitive sterile vial preparation integrated solutions, supporting the pharmaceutical industry in achieving efficient, safe, and compliant production. With our professional capabilities to ensure drug quality, we will collaborate with partners to promote high-quality development in the pharmaceutical sector.


About Morimatsu LifeSciences

Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.

Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.

Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.

Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.

As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.